Shares of cannabis company Tilray Brands (NASDAQ:TLRY) fell 13.5% in the morning session after the company reported ...

Cannabis company Tilray Brands (NASDAQ:TLRY) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 8.9% year ...

Stock futures edged lower on Friday morning as investors awaited the release of both the Jobs Report and Consumer Sentiment ...

Tilray Brands Inc.’s stock fell Friday after the beer and cannabis company said it expects a $20 million impact on its ...

Tilray Brands (TLRY) stock falls 8% in premarket after Q2 revenue misses estimates. However, company reaffirms FY25 guidance ...

Tilray Brands reported 9% YoY revenue growth in Q2 2025 to $210.95 million. Fiscal 2025 guidance remains strong at $950 ...

Alliance Global Partners lowered the firm’s price target on Tilray (TLRY) to $1.50 from $1.75 and keeps a Neutral rating on the shares.

The upcoming week will see a pick-up in earnings releases after little activity over the past couple holiday-shortened weeks.

New York hits $1B cannabis sales, Ukraine registers first medical product. Updates on DoorDash, Tilray, Agrify and more.

Tilray (TLRY) to announce Q2 earnings on January 10th, with expected revenue growth and recent stock decline compared to S&P 500.

Year, Reaching $61 Million in Q2 with Growth Across All Four Business Segments. Achieved 9% Year-Over-Year Growth, Generating Record Q2 Net ...

Cannabis company Tilray Brands (NASDAQ:TLRY) will be reporting results tomorrow morning. Here’s what to expect.